An international controlled clinical study published in The New England Journal of Medicine demonstrates that liquid biopsy can help identify…
Bladder cancer
The phase 3 open-label, randomized NIAGARA trial was designed to evaluate the benefits of adding perioperative immunotherapy durvalumab to standard…